compound 66 [PMID: 21802293]   Click here for help

GtoPdb Ligand ID: 8212

Compound class: Synthetic organic
Comment: Compound 66 is reported in [1], a medicinal chemistry/structure-based design study to identify improved inhibitors of BRAFV600E.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 134.45
Molecular weight 477.07
XLogP 4.01
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1n[nH]c2c1cc(cn2)NC(=O)c1c(F)ccc(c1F)NS(=O)(=O)c1cccc(c1)F
Isomeric SMILES COc1n[nH]c2c1cc(cn2)NC(=O)c1c(F)ccc(c1F)NS(=O)(=O)c1cccc(c1)F
InChI InChI=1S/C20H14F3N5O4S/c1-32-20-13-8-11(9-24-18(13)26-27-20)25-19(29)16-14(22)5-6-15(17(16)23)28-33(30,31)12-4-2-3-10(21)7-12/h2-9,28H,1H3,(H,25,29)(H,24,26,27)
InChI Key WGFNXGPBPIJYLI-UHFFFAOYSA-N
Bioactivity Comments
Compound 66 inhibits the activity of BRAFV600E with an IC50 value of 0.7nM [1]. In the presence of 1μM compound 66, FGR, Src, FLT3, LCK, PTK6 and SRMS kinase activities are inhibited by >75% [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites Hs Inhibitor Inhibition - - - 1
[1]
Description: Measured as % inhibition using 1μM compound.